Largest pharmaceutical companies in the United States by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by net assets, at SGD 111.5B, ahead of Johnson & Johnson (SGD 105.2B) and Merck & Co (SGD 67.9B). Figures as of 20 Nov 2026, 06:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerSGD 111.5B
- Median
- SGD 842.8M
- Combined market value
- SGD 4.82T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | SGD 111.5B | SGD 202.5B | SGD 35.52 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | SGD 105.2B | SGD 829.5B | SGD 344.56 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | SGD 67.9B | SGD 422.3B | SGD 171.30 | 3.61% down | 45% up | ||
| 4 | Abbott LaboratoriesABT · Health Care | SGD 67.2B | SGD 232B | SGD 133.97 | 0.58% down | 16% down | ||
| 5 | Regeneron PharmaceuticalsREGN · Health Care | SGD 40.3B | SGD 123.2B | SGD 1,190.93 | 2.35% down | 28% up | ||
| 6 | Eli LillyLLY · Health Care | SGD 34.2B | SGD 1.55T | SGD 1,742.69 | 2.29% down | 33% up | ||
| 7 | Vertex PharmaceuticalsVRTX · Health Care | SGD 24.1B | SGD 170.3B | SGD 671.55 | 2.94% down | 27% up | ||
| 8 | Bristol-Myers SquibbBMY · Health Care | SGD 23.8B | SGD 153.8B | SGD 75.25 | 2.05% down | 30% up | ||
| 9 | ViatrisVTRS · Health Care | SGD 19B | SGD 29.4B | SGD 25.64 | 1.97% down | 99% up | ||
| 10 | Royalty PharmaRPRX · Health Care | SGD 12.5B | SGD 50.2B | SGD 87.35 | 1.38% down | 79% up | ||
| 11 | United TherapeuticsUTHR · Health Care | SGD 9.2B | SGD 30.7B | SGD 721.13 | 3.16% down | 22% up | ||
| 12 | Elanco Animal HealthELAN · Health Care | SGD 8.4B | SGD 16.9B | SGD 33.91 | 1.54% down | 26% up | ||
| 13 | BioMarin PharmaceuticalBMRN · Health Care | SGD 7.9B | SGD 15.3B | SGD 79.22 | 0.02% down | 17% up | ||
| 14 | ZoetisZTS · Health Care | SGD 4.3B | SGD 42.3B | SGD 104.20 | 5.59% down | 26% down | ||
| 15 | Ligand PharmaceuticalsLGND · Health Care | SGD 1.3B | SGD 7.4B | SGD 370.10 | 3.94% down | 50% up | ||
| 16 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 4B | SGD 20.77 | 0.92% down | 41% down | ||
| 17 | Praxis Precision MedicinesPRAX · Health Care | SGD 1.1B | SGD 11.2B | SGD 401.00 | 1.87% up | 86% up | ||
| 18 | Alnylam PharmaceuticalsALNY · Health Care | SGD 1B | SGD 25.5B | SGD 190.66 | 1.06% down | 66% down | ||
| 19 | Belite BioBLTE · Health Care | SGD 993.8M | SGD 7.9B | SGD 194.79 | 3.33% down | 43% up | ||
| 20 | InsmedINSM · Health Care | SGD 953.1M | SGD 40.9B | SGD 186.33 | 20.58% up | 40% down | ||
| 21 | Spyre TherapeuticsSYRE · Health Care | SGD 922.5M | SGD 12B | SGD 125.92 | 3.77% down | 332% up | ||
| 22 | Summit TherapeuticsSMMT · Health Care | SGD 849.8M | SGD 10.9B | SGD 13.63 | 0.67% up | 36% down | ||
| 23 | TG TherapeuticsTGTX · Health Care | SGD 835.8M | SGD 12.6B | SGD 83.68 | 1.88% down | 117% up | ||
| 24 | Corcept TherapeuticsCORT · Health Care | SGD 835.5M | SGD 9.2B | SGD 83.81 | 4.15% down | 10% down | ||
| 25 | Cogent BiosciencesCOGT · Health Care | SGD 820.8M | SGD 6.2B | SGD 35.78 | 0.25% down | 20% down | ||
| 26 | Protagonist TherapeuticsPTGX · Health Care | SGD 792.9M | SGD 10.4B | SGD 159.96 | 2.47% down | 51% up | ||
| 27 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 777.4M | SGD 11.9B | SGD 511.72 | 0.34% down | 27% down | ||
| 28 | Edgewise TherapeuticsEWTX · Health Care | SGD 673.6M | SGD 5.8B | SGD 53.10 | 0.48% down | 86% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | SGD 636.4M | SGD 6.2B | SGD 109.41 | 1.01% up | 108% up | ||
| 30 | Ionis PharmaceuticalsIONS · Health Care | SGD 630.8M | SGD 5.8B | SGD 35.11 | 0.62% down | 63% down | ||
| 31 | Oruka TherapeuticsORKA · Health Care | SGD 608.7M | SGD 8.5B | SGD 125.85 | 1.91% up | 255% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 601.1M | SGD 8B | SGD 56.30 | 1.25% up | 13% up | ||
| 33 | Definium TherapeuticsDFTX · Health Care | SGD 428.6M | SGD 5.2B | SGD 38.02 | 1.24% up | 168% up | ||
| 34 | ErascaERAS · Health Care | SGD 419.4M | SGD 6.4B | SGD 18.34 | 3.34% up | 395% up | ||
| 35 | Mirum PharmaceuticalsMIRM · Health Care | SGD 405.9M | SGD 8B | SGD 123.19 | 3.27% up | 34% up | ||
| 36 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 179.4M | SGD 10.4B | SGD 150.65 | 1.88% down | 18% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | SGD 148.1M | SGD 6B | SGD 62.30 | 3.86% down | 45% up | ||
| 38 | Axsome TherapeuticsAXSM · Health Care | SGD 113.9M | SGD 9.2B | SGD 175.00 | 1.25% up | 6% down | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | -SGD 91.3M | SGD 9.6B | SGD 27.59 | 2.24% down | 90% up | ||
| 40 | VeradermicsMANE · Health Care | -SGD 156.1M | SGD 6.8B | SGD 160.44 | 0.38% down | 231% up | ||
| 41 | PTC TherapeuticsPTCT · Health Care | -SGD 264.8M | SGD 6.3B | SGD 75.23 | 3.16% down | 21% down | ||
| 42 | CytokineticsCYTK · Health Care | -SGD 850.8M | SGD 9.2B | SGD 66.37 | 0.27% up | 19% down | ||
| 43 | BridgeBio PharmaBBIO · Health Care | -SGD 2.7B | SGD 19.6B | SGD 100.84 | 0.22% up | 21% up | ||
| 44 | AbbVieABBV · Health Care | -SGD 4.2B | SGD 646.4B | SGD 365.71 | 0.86% down | 25% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2898 SGD).
Questions and answers
Which pharmaceutical companies in the United States rank first by net assets?
Pfizer (SGD 111.5B), Johnson & Johnson (SGD 105.2B) and Merck & Co (SGD 67.9B) are the top three of the 44 pharmaceutical companies in the United States ranked by net assets as of 20 Nov 2026, 06:27 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by net assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by net assets have a combined market value of SGD 4.82T as of 20 Nov 2026, 06:27 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by net assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.